@ARTICLE{
author={van Dussen Laura,Zimran An,Akkerman EM,Aerts JMFG,Petakov Milan S,Elstein Deborah,Rosenbaum H,Aviezer David,Brill-Almon Einat,Chertkoff Raul,Maas M,Hollak CEM},
year={2013},
title={Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={50},
number={3},
pages={206-211},
document_type={Article},
} 

@ARTICLE{
author={Elstein Deborah,Cohn Gabriel M,Wang N,Djordjevic Maja S,Brutaru Costin,Zimran An},
year={2011},
title={Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={46},
number={1},
pages={119-123},
document_type={Article},
} 

